SIAPS received two years of funding from the U.S. Agency for International Development (USAID) in September 2015 to provide technical assistance to rebuild and strengthen the post-Ebola pharmaceutical supply chain management system and improve the supply chain and rational medicine use in Sierra Leone. To support these goals, SIAPS provides technical assistance for systems strengthening activities including governance and leadership, supply chain management and information for decision making.
Archive | Capacity BuildingRSS feed for this section
Rapport Consolidé des Ateliers de Formation Des Utilisateurs en Vue de L’implémentation du Système de Logistique Intégrée en Guinée
Du décembre 13, 2016 à l’avril 8, 2017, se sont déroulés, sur l’ensemble du territoire, des formations destinées aux utilisateurs en vue de l’implémentation du système de logistique intégrée en Guinée. L’objectif était de renforcer les connaissances, les compétences, et les aptitudes des utilisateurs afin d’assurer la remontée des données logistiques et la disponibilité constante des produits de qualité, à tous les niveaux. Les ateliers de formation ont regroupé les responsables impliqués dans la gestion des stocks au niveau central, au niveau de la ville de Conakry et au niveau des régions de Boké, Kindia, Mamou, Labé, Faranah, Kankan, et N’Zérékoré. À l’issue de ce déploiement, 511 utilisateurs ont été formés sur le Système d’Information pour la Gestion Logistique (SIGL) Intégrée. Ils sont désormais bien outillés pour produire et transmettre les données sur les médicaments qu’ils gèrent au niveau de leurs structures respectives.
In Mozambique, SIAPS has been working with the Ministry of Health’s (MOH) pharmaceutical department (PD), which functions as the country’s regulatory authority, to strengthen its capacity at the national level. The PD’s main function is to ensure access to safe, effective, and quality pharmaceuticals through the public and private sectors that contribute to the best possible health outcomes. One of the PD’s priorities has been to develop a monitoring and evaluation (M&E) system to assess department performance; improve transparency and ensure accountability; help guide the planning, coordination, and implementation of regulatory activities; and foster a culture of evidence-based decision making.
Supportive Supervision and Mentorship Site Visit for Pharmacy Services in the Shiselweni Region, Swaziland
With support from SIAPS and in collaboration with other development partners, the Central Medical Stores (CMS) conducts supportive supervision and mentorship (SSM) visits to health facilities. Through these visits, the capacity of health personnel is built to effectively manage pharmaceuticals and services, improve the rational use of pharmaceuticals, and strengthen supply chain management at all levels of health care delivery.
In 2014, SIAPS supported the Ministry of Health (MOH), Central Medical Stores (CMS), and Swaziland Health Laboratory Services (SHLS) by conducting a workshop to build capacity and improve performance of staff that works in warehouse operations. The Imperial Health Services warehouse was used as a model to showcase warehousing best practices.
Pharmaceutical Leadership and Governance Initiative in the Free State Province, November 2015–May 2016
The PLGI was implemented in the Free State Province from September 2015 to May 2016. Thirty-two pharmacists from primary health care (PHC) centers, hospitals, districts, and the provincial health depot successfully completed the program. The results achieved, together with the challenges faced by the pharmacy district teams, were presented at a final presentation workshop held in Bloemfontein in May 2016.
The LDP was offered to health care professionals in the Northern/Tygerberg Sub-Structure (NTSS), Western Cape Province. Twenty-four health care professionals (12 facility managers and 12 pharmacy supervisors) from primary health care facilities across the sub-structure were enrolled in the program in September 2012. The results achieved, together with the challenges faced by the NTSS facility teams, were presented at a final presentation workshop held in Cape Town in November 2014. Seven of the twelve teams (58%) had achieved their desired measurable results by the end of the six-month period.
Establishment of Pre-Service Mid-Level Pharmacy Training in Swaziland: From Assessment to Implementation
To assess the feasibility of launching a pharmacy training program or programs in Swaziland, the assessment considered the establishment of different pharmacy training programs with different training models, taking into consideration market requirements in both the public and private sectors. The feasibility assessment recommended the ideal curriculum to be adopted for Swaziland.
South Sudan’s health system is struggling to overcome a myriad of challenges, including poor pharmaceutical supply management practices, weak infrastructure, and inadequate skilled manpower. The outbreak of civil unrest in the nascent nation in December 2013 further exacerbated the already dire situation. South Sudan has one of the highest maternal mortality rates in the world, estimated at 789/100,000 live births. The country’s HIV prevalence rate increased from about 2% in 2000 to 2.6% in 2015 among adults, according to the South Sudan HIV/AIDS Commission and Ministry of Health. As of 2014, only 6% of 15 million people living with HIV were on antiretroviral therapy (ART).
Swaziland is one of three remaining countries in the Southern Africa Development Community Region that do not have adequate regulatory and legislative frameworks to control the use, importation, manufacturing, and exportation of medicines. This is in the face of increased incidence of counterfeit medicines in the region; up to 25% of marketed medicines are substandard, and this is up to 64% for antimalarial medicines, according to a study conducted in 2011. Use of counterfeit and substandard medicines increases the burden of disease because of therapeutic failure, exacerbation of disease, and resistance to medicines. Swaziland’s weakness in medicines regulation and limited regulatory enforcement is also exploited by those smuggling prohibited and counterfeit medicines into neighboring countries.